No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Ibrance is a type of breast cancer drug used to treat certain types of breast cancer in postmenopausal women. It is a type of hormone therapy, which works by blocking the action of the hormone estrogen in the body. Ibrance is used in combination with other drugs, such as letrozole, to treat advanced or metastatic breast cancer. It is also used to reduce the risk of recurrence in women who have already been treated for early-stage breast cancer.
Ibrance is a relatively new drug, having been approved by the US Food and Drug Administration in 2015. It is a targeted therapy, meaning it works by targeting specific molecules in the body that are involved in the growth and spread of cancer cells.
Ibrance is marketed by Pfizer, Inc., and is available in both tablet and capsule form. Other companies in the market include Novartis, AstraZeneca, and Eli Lilly. Show Less Read more
